What determines the tissue-specific vulnerability pattern in CHCHD10 mutations (heart > muscle > neurons)?

OPEN

Despite ubiquitous CHCHD10 expression, the mutation causes fatal cardiomyopathy by 14 months, muscle defects by 3 months, but only moderate motor neuron loss at end-stage disease. The molecular basis for this differential tissue vulnerability is unknown but could reveal therapeutic targets. Gap type: unexplained_observation Source paper: Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10 (2019, Acta neuropathologica, PMID:30874923)

Priority: 0.78 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What determines the tissue-specific vulnerability pattern in CHCHD10 mutations (heart > muscle > neurons)? is a 0.78 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What determines the tissue-specific vulnerability pattern in CHCHD10 mutations (heart > muscle > neurons)? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (2)

CHCHD10MOTOR NEURONSCHCHD10TDP-43

associated with (9)

CHCHD10neurodegenerationCHCHD10AlsCHCHD10GRNCHCHD10MAPTNEK1CHCHD10
▸ Show 4 more

causes (17)

CHCHD10ALSALSCHCHD10CHCHD10MITOCHONDRIAL DYSFUNCTIONCHCHD10OPA1CHCHD10PRNP
▸ Show 12 more

inhibits (2)

CHCHD10TDP-43CHCHD10APOPTOSIS

interacts with (14)

CHCHD10AMYOTROPHIC LATERAL SCLEROSISCHCHD10NEURONTDP-43CHCHD10CHCHD10FUSCHCHD10TMEM175
▸ Show 9 more

participates in (1)

CHCHD10oxidative stress response

regulates (1)

CHCHD10OPA1

therapeutic target (3)

CHCHD10Amyotrophic Lateral SclerosisCHCHD10MsCHCHD10SOD1

treats (1)

PINK1CHCHD10
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps